Latest Securities Issuance News

Askari Metals has addressed an ASX query regarding the late filing of a director's securities interest notice, attributing the delay to awaiting regulatory guidance following an inadvertent related party securities breach.

BOA Resources has completed the issuance of securities tied to its $3.75 million placement after securing shareholder approval earlier this month.

Askari Metals has responded to an ASX query regarding an inadvertent breach of Listing Rule 10.11 after issuing securities to a related party without prior shareholder approval during a recent rights issue. The company outlines the circumstances and its planned remedial actions.

Lycopodium Limited has addressed ASX concerns over delayed director interest disclosures, attributing the lapse to an administrative oversight while reaffirming its compliance policies.

Conico Ltd has raised $2.8 million through a share placement and entitlement offer, appointing Guy Le Page as Executive Chairman to steer its next exploration phase.

Patrys Limited has expanded its clinical pipeline by acquiring Reliis Pty Ltd, gaining a proprietary injectable formulation of Quetiapine aimed at the large and underserved delirium market. This strategic move balances Patrys’ portfolio with a near-term pharmaceutical asset alongside its biologics program.

Visionflex Group Limited has successfully passed all resolutions at its 2025 Annual General Meeting, reinforcing its governance framework and capital strategy.

Australian Critical Minerals has completed a strategic acquisition of Circuit Resources, adding six multi-commodity projects in Peru and initiating exploration activities with drilling planned for late 2025.

Western Mines Group has completed a major capital raising, issuing over 16.5 million shares and unlisted options to fund expanded exploration at its Mulga Tank project.

Emu NL has agreed to delay issuing shortfall securities tied to its recent entitlement offer until late October, as the Takeovers Panel continues its review following a challenge by Dronkay Pty Ltd.

Anteris Technologies has gained shareholder approval for an ASX waiver allowing flexible capital raising and updated its PARADIGM trial timeline, now set to begin patient enrolment in Q4 2025 after addressing FDA requests.

Emu NL has agreed to delay issuing shortfall securities from its entitlement offer until after its extraordinary general meeting on 29 September 2025, following a regulatory undertaking accepted by the Takeovers Panel.